Filed by BioPharmX Corporation pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-6
under the Securities Exchange Act of 1934
Subject Company: BioPharmX Corporation (SEC File No. 001-37411)
Commission File No. for the Related Registration Statement: 333-236526
900 E. Hamilton Ave., Suite 100
Campbell, CA 95008
(650) 889-5020
www.BioPharmX.com
Dear BioPharmX Shareholder:
YOUR PARTICIPATION IS IMPORTANT – PLEASE VOTE TODAY!
According to our latest records, your proxy vote relating to the BioPharmX Special Meeting of Stockholders has not yet been received.
| You have untilMay 12 2020, at 11:59 p.m. EST to vote your shares. PLEASE VOTE TODAY using the link that accompanied this letter. |
BioPharmX appreciates your investment and asks for your vote on the following items:
| Item 1 | APPROVE ISSUANCE OF BIOPHARMX'S COMMON STOCK TO TIMBER'S MEMBERS | VoteFOR |
| Item 2 | APPROVE A REVERSE STOCK SPLIT OF BIOPHARMX'S COMMON STOCK | VoteFOR |
| Item 3 | APPROVE AMENDMENT FOR CHANGE IN CORPORATE NAME | VoteFOR |
| Item 4 | APPROVE TIMBER PHARMACEUTICALS 2020 OMNIBUS EQUITY INCENTIVE PLAN | VoteFOR |
| Item 5 | APPROVE ISSUANCE OF STOCK UPON EXERCISE OF INVESTOR WARRANT | VoteFOR |
| Item 6 | ADJOURN THE MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES | VoteFOR |
| Item 7 | TRANSACT OTHER BUSINESS AS MAY COME BEFORE THE SPECIAL MEETING | VoteFOR |
If you have any questions please contact our proxy solicitor Alliance Advisors toll free at: (833) 782-7191.
If you have recently mailed your proxy card or cast your vote by phone or internet, please accept our thanks and disregard this request.
Sincerely,
Steven M. Bosacki
Chief Executive Officer